Evidence map›Paper›PMID 32978476›Full record

ArticleScientific reports2020

Animal heat activated cancer therapy by a traditional catalyst TiO

Yanlong Yu, Pengchong Jiang, Yabin Yan, Hanbo Li, Lixin Zhang, Shan Jiang, Wensheng Yang, Yaan Cao

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yanlong YuKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, 300457, People's Republic of China.
Pengchong JiangKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, 300457, People's Republic of China.
Yabin YanKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, 300457, People's Republic of China.
Hanbo LiKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, 300457, People's Republic of China.
Lixin ZhangKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, 300457, People's Republic of China.
Shan JiangCollege of Chemistry, Jilin University, Changchun, 130012, People's Republic of China.
Wensheng YangCollege of Chemistry, Jilin University, Changchun, 130012, People's Republic of China.
Yaan CaoKey Laboratory of Weak-Light Nonlinear Photonics, Ministry of Education, TEDA Applied Physics Institute and School of Physics, Nankai University, Tianjin, 300457, People's Republic of China. caoya@nankai.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer therapy is one of the most important challenges in clinical medicine. So far different methods have been developed for cancer therapy, such as radiation therapy, surgery, chemotherapy and photodynamic therapy. Here we propose a new concept for cancer therapy, i.e., killing the cancer cells simply via reactive oxygen species (ROS) generated by TiO

Indexed as

Hot TemperaturePhotochemotherapyAnimalsApoptosisCatalysisCell ProliferationGraphiteHumansLung NeoplasmsMetal NanoparticlesMiceMice, Inbred BALB CPalladiumReactive Oxygen SpeciesTitaniumTumor Cells, CulturedGraphitePalladiumReactive Oxygen SpeciesTitaniumtitanium dioxide

Identifiers

PMID32978476
PMCPMC7519649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.